🇺🇸 FDA
Patent

US 7346387

Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents

granted A61KA61K41/008A61K49/0017

Quick answer

US patent 7346387 (Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents) held by Provectus Devicetech, Inc. expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Devicetech, Inc.
Grant date
Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K41/008, A61K49/0017, A61K49/0039, A61K49/0043